Table 1 Twelve true/false questions with the answers
Question | Answer |
|---|---|
1. Precancerous cervical lesions and cervical cancer are strongly associated with sexually transmitted high-risk HPV infection, which causes more than 97% of cervical cancers. | True |
2. HPV types 16 and 18 are high-risk strains that cause around 70% of all cervical cancers. | True |
3. The low-risk HPV (types 6 and 11) cause 90–95% of anogenital warts and 30% of cervical cancers. | False |
4. HPV vaccine can reduce the risk of cancers include cervix, vaginal, vulvar, anal, penile, and oropharyngeal cancers. | True |
5. Cytology is more sensitive than HPV testing in detecting CIN2 and CIN3. | False |
6. Women with visible cervical lesions on speculum examination should undergo screening for cervical cancer. | False |
7. For women age 30 to 65 years, cytology alone every three years is the preferred method of cervical cancer screening. | False |
8. Annual screening for cervical cancer is not recommended for women with average risks at all ages. | True |
9. Women who underwent total hysterectomy with removal of the cervix unrelated to cancer should continue to screen for 20 years with cytology every three years. | False |
10. The Centers for Disease Control and Prevention recommended for HPV vaccination to include vaccinating boys and girls before 15 years of age, and as early as nine years of age. | True |
11. A two-dose series of HPV vaccine is used when initiated before 12 years of age, whereas a three-dose series is required if initiated at 12 years or older. | False |
12. If Cervarix (bivalent vaccine) or Gardasil (quadrivalent vaccine) has already been given, the patient should be revaccinated using Gardasil-9 due to more coverage of HPV genotypes. | False |